BioCentury
ARTICLE | Company News

Wilex licenses antigen from Bayer

November 12, 2001 8:00 AM UTC

Wilex (Munich, Germany) received a license from Bayer (FSE:BAYG) to patents covering MN, a tumor associated antigen. Wilex said the patents relate to its WX-G250 antibody and a radiolabeled version of...